The Cardiac Channelopathy Gene Panel Test is a specialized diagnostic tool designed to detect genetic mutations associated with cardiac channelopathies, a group of disorders that affect the heart’s electrical activity and can lead to arrhythmias and sudden cardiac death. This comprehensive test examines multiple genes known to be involved in these conditions, providing crucial information for accurate diagnosis, management, and familial risk assessment.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced sequencing technologies to ensure high sensitivity and specificity. With a cost of 7200 AED, it represents a significant investment in personal health, offering insights that can guide preventive measures, treatment decisions, and inform family members about their potential risks. The results from this test can be pivotal in developing personalized management plans for individuals with or at risk of cardiac channelopathies, ultimately aiming to improve outcomes and reduce the risk of life-threatening cardiac events.
The “Common Neurological Neuromuscular Diseases Gene Panel Test” is a sophisticated diagnostic tool designed to identify genetic mutations associated with a range of neurological and neuromuscular disorders. Conducted at DNA Labs UAE, this comprehensive test analyzes multiple genes simultaneously, offering insights into conditions that affect the brain, spinal cord, peripheral nerves, and muscles. These disorders may include, but are not limited to, muscular dystrophies, amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and various types of neuropathies.
The test is particularly valuable for individuals with symptoms suggestive of neurological or neuromuscular diseases, families with a history of such conditions, or for those seeking a precise diagnosis to guide treatment and management strategies. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then examined using advanced genetic sequencing techniques.
Priced at 7200 AED, the test is an investment in health, offering potential benefits such as early detection, personalized treatment plans, and the opportunity to make informed decisions about family planning. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic testing, ensuring accurate and reliable results. This test represents a crucial step forward in the diagnosis and understanding of complex neurological and neuromuscular diseases, empowering patients and healthcare providers with critical information for managing these challenging conditions.
The Complete Inherited Disease Panel Test, available at DNA Labs UAE for a cost of 7200 AED, is a comprehensive genetic screening tool designed to identify the presence of genetic mutations associated with a wide range of inherited diseases. This cutting-edge test covers a vast array of genetic disorders, offering individuals and families crucial insights into their genetic health and predisposition towards various inherited conditions. By analyzing the DNA, this panel can detect mutations that could lead to conditions such as cystic fibrosis, sickle cell anemia, various forms of heart disease, and many others, enabling early detection and intervention strategies. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy, confidentiality, and professional guidance throughout the testing process.
The Comprehensive Hereditary Cancer Panel 154 Genes Test, available at DNA Labs UAE for 7200 AED, is a state-of-the-art genetic screening designed to assess an individual’s risk for various hereditary cancers. This extensive test analyzes 154 genes known to be associated with an increased risk of developing cancer, including but not limited to breast, ovarian, colorectal, and pancreatic cancers. By examining a person’s DNA, the test identifies specific mutations that could signify a higher likelihood of cancer, enabling early detection and proactive management strategies. The results from this panel can provide valuable information for both the individual tested and their family members, as certain genetic mutations may be inherited. Conducted in the advanced facilities of DNA Labs UAE, this test is a powerful tool in the ongoing fight against cancer, offering individuals insights into their genetic makeup and helping them make informed decisions about their health and preventive care.
The “Deafness Gene Panel Test,” available at DNA Labs UAE, is a comprehensive genetic screening designed to identify mutations in genes known to be associated with hearing loss. Priced at 7200 AED, this test is a valuable tool for individuals who are experiencing hearing difficulties or have a family history of deafness. By analyzing a wide array of genes linked to various forms of hereditary deafness, the test can provide insights into the genetic basis of an individual’s hearing loss, facilitating personalized treatment and management strategies. Conducted in a state-of-the-art facility, the Deafness Gene Panel Test at DNA Labs UAE represents a critical step forward in the diagnosis and understanding of genetic hearing loss conditions.
The Dystonia Gene Panel Test, available at DNA Labs UAE, is a sophisticated diagnostic tool designed to identify genetic mutations associated with dystonia, a complex neurological movement disorder. This condition is characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. Dystonia can affect just one muscle, a group of muscles, or muscles throughout the body, and it can be a primary condition or a symptom of another disease.
The test, which costs 7200 AED, involves analyzing a comprehensive panel of genes known to be linked to various forms of dystonia. By examining a patient’s DNA, the test aims to pinpoint specific genetic abnormalities that may be causing or contributing to the disorder. This targeted approach not only aids in confirming a diagnosis of dystonia but also helps in understanding the type and potential severity of the condition. Furthermore, the results can guide treatment decisions, assist in predicting the course of the disease, and provide valuable information for family planning.
DNA Labs UAE employs state-of-the-art genetic testing technology to ensure accurate and reliable results. The test is performed under strict quality controls and is interpreted by experts in genetics and neurology. For individuals exhibiting symptoms of dystonia or those with a family history of the disorder, the Dystonia Gene Panel Test offers a crucial step towards achieving a clearer understanding of their condition and exploring appropriate treatment options.
Early Infantile Epileptic Encephalopathy (EIEE), also known as Ohtahara Syndrome, is a severe neurological condition characterized by frequent seizures and significant developmental delays. These seizures typically begin in the first few months of life and are often resistant to treatment. Due to its genetic underpinnings, understanding the specific genetic mutations involved can be crucial for diagnosis, management, and treatment planning.
The Early Infantile Epileptic Encephalopathy Gene Panel Test is a comprehensive diagnostic tool designed to identify genetic mutations associated with EIEE. By analyzing a broad array of genes known to be linked to this condition, the test provides valuable insights that can guide medical professionals in tailoring the most effective treatment strategies for each individual patient.
Administered at DNA Labs UAE, a leading facility in genetic testing, the test ensures high accuracy and reliability. The test cost is set at 7200 AED, reflecting the extensive analysis and expert interpretation involved in identifying the genetic factors contributing to the condition. Through this test, families and healthcare providers can gain a deeper understanding of the disorder, paving the way for personalized treatment approaches and improved outcomes for affected infants.
The Oncomine Lung cfTNA Cancer Panel Test, available at DNA Labs UAE for a cost of 10,500 AED, is a highly advanced diagnostic tool designed for the detection and analysis of circulating free tumor nucleic acids (cfTNA) in the blood of patients suspected to have lung cancer. This non-invasive test utilizes next-generation sequencing (NGS) technology to identify genetic mutations and alterations in cfTNA that are associated with lung cancer. By analyzing a simple blood sample, the test can provide critical information on the genetic makeup of lung tumors, aiding clinicians in making more informed decisions regarding treatment strategies. This approach not only offers a convenient alternative to traditional tissue biopsies but also enables the monitoring of tumor dynamics and resistance mechanisms over time. DNA Labs UAE, by offering this cutting-edge test, demonstrates its commitment to providing state-of-the-art diagnostic solutions to improve patient care and outcomes in the fight against lung cancer.
The Wilson Disease ATP7B Gene Mutation Detection Test is a specialized diagnostic procedure aimed at identifying mutations in the ATP7B gene, which are responsible for Wilson Disease. Wilson Disease is a rare genetic disorder that leads to excessive accumulation of copper in the body, affecting the liver, brain, and other vital organs. Early detection and treatment are crucial for managing the disease effectively.
This test is conducted by DNA Labs UAE, a leading facility in genetic testing, ensuring high accuracy and reliability of results. By analyzing the patient’s DNA, the test can pinpoint specific mutations in the ATP7B gene, confirming the diagnosis of Wilson Disease. This information is vital for clinicians to devise appropriate treatment plans and for affected families to understand the risk of inheritance.
The cost of the Wilson Disease ATP7B Gene Mutation Detection Test at DNA Labs UAE is 10,500 AED. Although the price may seem high, the test offers invaluable insights into managing and treating a potentially life-threatening condition, making it a critical investment in the health and well-being of individuals at risk for or suspected of having Wilson Disease.
Autoimmune Cerebellar Ataxia Panel Test is a specialized diagnostic examination designed to identify the presence of specific antibodies that may contribute to autoimmune cerebellar ataxia, a condition where the immune system mistakenly attacks the cerebellum, part of the brain that controls coordination and balance. This comprehensive panel aims to facilitate the accurate diagnosis of autoimmune-related cerebellar ataxia, distinguishing it from other types of ataxia caused by genetic factors, toxins, or other diseases. Conducted at DNA Labs UAE, a facility known for its advanced diagnostic technologies and expertise in genetic and autoimmune disorders, the test costs 11,790 AED. By pinpointing the exact antibodies causing the immune response, healthcare providers can tailor treatment plans more effectively, offering hope for improved management of symptoms and quality of life for affected individuals.
